Release behaviour and toxicity evaluation of levodopa from carboxylated single-walled carbon nanotubes

Scholarly Works

• Deng, Y.; Feng, Y.; Ye, B.; Hu, L.; Qi, L.; Wang, C.; Zhou, C.; Liu, G.; Gao, X.; Lin, C.; Ding, Q.; Zhao, Z.; Song, C.; Qian, B.; Wu, T.; Wang, X.; Liu, Z.; Lin, Z.; Zhang, M. Application of nanomaterials in central nervous system disorders. Psychopharmacology 2025. doi:10.1007/s00213-025-06862-3
• Allevi, D.; Luchicchi, A.; Orefice, N. S. Nanocarrier-based drug delivery for mild cognitive impairment: Extracellular vesicles and carbon nanotubes as emerging therapeutic tools. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2025, 190, 118381. doi:10.1016/j.biopha.2025.118381
• Kanjilal, B.; Okoro, P. D.; Jaberi, R.; Taepakdee, A.; Sharifi, N.; Morgan, J.; Santhakumar, V.; Rodgers, V. G.; Masoumi, A.; Noshadi, I. Advances in carbon nanomaterials and their polymeric composites in neural tissue engineering. Advanced drug delivery reviews 2025, 224, 115658. doi:10.1016/j.addr.2025.115658
• Alvandi, H.; Shafie, A.; Najafi, F.; Sabzini, M.; Mashayekhi, M.; Omami, S. H.; Eskandarisani, M. M.; Dashti, S.; Javanmard, A.; Tajik, M.; Bräse, S.; Farmani, A. R. Carbon-based nanostructure drug delivery systems and their biologic applications – a review. Carbon Letters 2025, 35, 1529–1587. doi:10.1007/s42823-025-00927-1
• Razavi, Z. S.; Razavi, F. S.; Alizadeh, S. S. Inorganic nanoparticles and blood-brain barrier modulation: Advancing targeted neurological therapies. European journal of medicinal chemistry 2025, 287, 117357. doi:10.1016/j.ejmech.2025.117357
• Yadav, V. K.; Dhanasekaran, S.; Choudhary, N.; Nathiya, D.; Thakur, V.; Gupta, R.; Pramanik, S.; Kumar, P.; Gupta, N.; Patel, A. Recent advances in nanotechnology for Parkinson's disease: diagnosis, treatment, and future perspectives. Frontiers in medicine 2025, 12, 1535682. doi:10.3389/fmed.2025.1535682
• Parhi, R. Nanoparticle-mediated drug delivery for neurodegenerative diseases. The Neurodegeneration Revolution; Elsevier, 2025; pp 267–307. doi:10.1016/b978-0-443-28822-7.00013-1
• Gupta, B.; Sharma, P. K.; Malviya, R. Carbon Nanotubes for Targeted Therapy: Safety, Efficacy, Feasibility and Regulatory Aspects. Current pharmaceutical design 2024, 30, 81–99. doi:10.2174/0113816128282085231226065407
• Sameer, M.; Arif, Y.; Aqil, A.; Nadaf, A.; Rafiya, K.; Hasan, N.; Kesharwani, P.; Ahmad, F. J. Carbon nanodots as a remedial nanovesicles for drug delivery. European Polymer Journal 2023, 200, 112515. doi:10.1016/j.eurpolymj.2023.112515
• Elsori, D.; Rashid, G.; Khan, N. A.; Sachdeva, P.; Jindal, R.; Kayenat, F.; Sachdeva, B.; Kamal, M. A.; Babker, A. M.; Fahmy, S. A. Nanotube breakthroughs: unveiling the potential of carbon nanotubes as a dual therapeutic arsenal for Alzheimer's disease and brain tumors. Frontiers in oncology 2023, 13, 1265347. doi:10.3389/fonc.2023.1265347
• Wu, D.; Chen, Q.; Chen, X.; Han, F.; Chen, Z.; Wang, Y. The blood-brain barrier: structure, regulation, and drug delivery. Signal transduction and targeted therapy 2023, 8, 217. doi:10.1038/s41392-023-01481-w
• Cifuentes, J.; Cifuentes-Almanza, S.; Ruiz Puentes, P.; Quezada, V.; González Barrios, A. F.; Calderón-Peláez, M.-A.; Velandia-Romero, M. L.; Rafat, M.; Muñoz-Camargo, C.; Albarracín, S. L.; Cruz, J. C. Multifunctional magnetoliposomes as drug delivery vehicles for the potential treatment of Parkinson's disease. Frontiers in bioengineering and biotechnology 2023, 11, 1181842. doi:10.3389/fbioe.2023.1181842
• Kabirian, F.; Baatsen, P.; Smet, M.; Shavandi, A.; Mela, P.; Heying, R. Carbon nanotubes as a nitric oxide nano-reservoir improved the controlled release profile in 3D printed biodegradable vascular grafts. Scientific reports 2023, 13, 4662. doi:10.1038/s41598-023-31619-3
• Asil, S. M.; Guerrero, E. D.; Bugarini, G.; Cayme, J.; De Avila, N.; Garcia, J.; Hernandez, A.; Mecado, J.; Madero, Y.; Moncayo, F.; Olmos, R.; Perches, D.; Roman, J.; Salcido-Padilla, D.; Sanchez, E.; Trejo, C.; Trevino, P.; Nurunnabi, M.; Narayan, M. Theranostic applications of multifunctional carbon nanomaterials. View (Beijing, China) 2023, 4. doi:10.1002/viw.20220056
• Palaniappan, N.; Kujawska, M.; Poturcu, K. doi:10.1002/9781119905080.ch6
• Mittal, P.; Hazari, P. P. Nanotubes-based brain targeted drug delivery system: a step toward improving bioavailability and drug enhancement at the target site. Fiber and Textile Engineering in Drug Delivery Systems; Elsevier, 2023; pp 417–441. doi:10.1016/b978-0-323-96117-2.00009-1
• Singh, J.; Nayak, P.; Singh, G.; Khandai, M.; Sarangi, R. R.; Kar, M. K. Carbon Nanostructures as Therapeutic Cargoes: Recent Developments and Challenges. 2022, 9, 3. doi:10.3390/c9010003
• Shankar, J.; K.M, G.; Wilson, B. Potential applications of nanomedicine for treating Parkinson's disease. Journal of Drug Delivery Science and Technology 2021, 66, 102793. doi:10.1016/j.jddst.2021.102793
• Saylam, E.; Akkaya, Y.; Ilhan, E.; Cesur, S.; Guler, E.; Sahin, A.; Cam, M. E.; Ekren, N.; Oktar, F. N.; Gunduz, O.; Ficai, D.; Ficai, A. Levodopa-Loaded 3D-Printed Poly (Lactic) Acid/Chitosan Neural Tissue Scaffold as a Promising Drug Delivery System for the Treatment of Parkinson’s Disease. Applied Sciences 2021, 11, 10727. doi:10.3390/app112210727
• Rahamathulla, M.; Bhosale, R. R.; Osmani, R. A. M.; Mahima, K. C.; Johnson, A. P.; Hani, U.; Ghazwani, M.; Begum, M. Y.; Alshehri; Ghoneim, M. M.; Shakeel, F.; Gangadharappa, H. Carbon Nanotubes: Current Perspectives on Diverse Applications in Targeted Drug Delivery and Therapies. Materials (Basel, Switzerland) 2021, 14, 6707. doi:10.3390/ma14216707

Explore citations to this article at